Moderna shares fall despite promising data from cancer vaccine trial
April 17, 2023 at 11:30 AM EDT
Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Moderna shares fall despite promising data from cancer vaccine trialApril 17, 2023 at 11:30 AM EDT
Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|